While IL-1R deletion in epithelial cells blocks CRC progression independent of inflammation, the same defects in the T cells and the myeloid cells (mainly neutrophil) restrict and exacerbate tumor growth and progression, respectively, following the microbial invasion in tumors (104). The gene discussed is IL1R1; the disease is colorectal carcinoma.